$CLPS
CLPS Inc Stock $clps

$clps Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 20-F Financial Statement

#000101376223004641 Filed on October 18, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2023
Revenue		$73.60M	$150.4M
YoY Change		-3.29%	-1.1%
Cost Of Revenue		$57.57M	$115.9M
YoY Change		0.25%	4.36%
Gross Profit		$16.02M	$34.48M
YoY Change		-14.23%	-15.88%
Gross Profit Margin		21.77%	22.93%
Selling, General & Admin		$11.56M	$24.94M
YoY Change		-26.35%	-8.13%
% of Gross Profit		72.16%	72.33%
Research & Development		$3.980M	$8.337M
YoY Change		4.85%	4.59%
% of Gross Profit		24.84%	24.18%
Depreciation & Amortization			$1.220M
YoY Change			33.71%
% of Gross Profit			3.54%
Operating Expenses		$14.91M	$34.41M
YoY Change		-20.83%	2.45%
Operating Profit		$1.110M	$76.39K
YoY Change		-809.95%	-98.97%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net		$480.0K	$18.03M
YoY Change		4.76%	7.48%
Pretax Income		-$790.0K	$4.350M
YoY Change		-361.72%	-74.95%
Income Tax		$490.0K	$674.3K
% Of Pretax Income			15.5%
Net Earnings		-$1.070M	$192.5K
YoY Change		-40.79%	-95.8%
Net Earnings / Revenue		-1.45%	0.13%
Basic Earnings Per Share			$0.01
Diluted Earnings Per Share		-$0.05	$0.01
COMMON SHARES
Basic Shares Outstanding	25.59M shares		23.15M shares
Diluted Shares Outstanding			23.15M shares

Balance Sheet

Concept	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$22.20M	$22.20M
YoY Change	20.67%	20.67%
Cash & Equivalents	$22.21M	$22.20M
Short-Term Investments
Other Short-Term Assets	$391.3K	$1.800M
YoY Change	-90.72%	-57.3%
Inventory
Prepaid Expenses	$510.5K
Receivables	$48.52M	$48.50M
Other Receivables	$400.0K	$400.0K
Total Short-Term Assets	$72.87M	$72.90M
YoY Change	-5.06%	-5.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$20.11M	$20.90M
YoY Change	-2.37%	1.45%
Goodwill
YoY Change
Intangibles	$726.2K
YoY Change	-25.14%
Long-Term Investments	$500.0K	$500.0K
YoY Change	139.32%	-18.09%
Other Assets	$300.0K	$300.0K
YoY Change	-47.87%	-47.87%
Total Long-Term Assets	$22.44M	$22.40M
YoY Change	-10.65%	-10.83%
TOTAL ASSETS
Total Short-Term Assets	$72.87M	$72.90M
Total Long-Term Assets	$22.44M	$22.40M
Total Assets	$95.32M	$95.30M
YoY Change	-6.44%	-6.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$690.0K	$700.0K
YoY Change	68.1%	70.53%
Accrued Expenses	$11.60M	$11.60M
YoY Change	-7.62%	-7.62%
Deferred Revenue	$918.5K
YoY Change	56.43%
Short-Term Debt	$10.60M	$10.60M
YoY Change	-26.77%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$26.31M	$26.30M
YoY Change	-13.39%	-13.44%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$885.9K	$3.300M
YoY Change	-75.02%	-6.94%
Total Long-Term Liabilities	$885.9K	$3.300M
YoY Change	-75.02%	-6.94%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.31M	$26.30M
Total Long-Term Liabilities	$885.9K	$3.300M
Total Liabilities	$29.81M	$30.70M
YoY Change	-12.53%	-13.1%
SHAREHOLDERS EQUITY
Retained Earnings	$5.029M
YoY Change	-20.47%
Common Stock	$2.365K
YoY Change	5.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$64.58M	$64.60M
YoY Change
Total Liabilities & Shareholders Equity	$95.32M	$95.30M
YoY Change	-6.44%	-6.46%

Cashflow Statement

Concept	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	-$1.070M	$192.5K
YoY Change	-40.79%	-95.8%
Depreciation, Depletion And Amortization		$1.220M
YoY Change		33.71%
Cash From Operating Activities		$9.706M
YoY Change		203.23%
INVESTING ACTIVITIES
Capital Expenditures		$519.3K
YoY Change		-97.5%
Acquisitions
YoY Change
Other Investing Activities		$210.0K
YoY Change		-95.3%
Cash From Investing Activities		-$306.0K
YoY Change		-98.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-$4.319M
YoY Change		-157.79%
NET CHANGE
Cash From Operating Activities		$9.706M
Cash From Investing Activities		-$306.0K
Cash From Financing Activities		-$4.319M
Net Change In Cash		$3.905M
YoY Change		-161.56%
FREE CASH FLOW
Cash From Operating Activities		$9.706M
Capital Expenditures		$519.3K
Free Cash Flow		$9.187M
YoY Change		-152.35%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38505
CY2023	dei	Entity Registrant Name EntityRegistrantName	CLPS Incorporation
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	c/o Unit 1000, 10th Floor, Millennium City III
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	370 Kwun Tong Road, Kwun Tong
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Kowloon
CY2023	dei	Entity Address Country EntityAddressCountry	HK
CY2023	dei	Security12b Title Security12bTitle	Common Shares, par value $0.0001
CY2023	dei	Trading Symbol TradingSymbol	CLPS
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25586122	shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	1408
CY2023	dei	Auditor Name AuditorName	Ernst & Young Hua Ming LLP
CY2023	dei	Auditor Location AuditorLocation	Shanghai, the People’s Republic of China
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22214029	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18396987	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	87604	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	48515467	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	53769887	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1665736	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4215414	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	391271	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	377642	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	72874107	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	76759930	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20112305	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20601098	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	726175	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	970044	usd
CY2022Q2	us-gaap	Goodwill Goodwill	2363841	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	815324	usd
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	456598	usd
CY2022Q2	us-gaap	Long Term Investments LongTermInvestments	610386	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	252656	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	248456	usd
CY2023Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	81899	usd
CY2022Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	327040	usd
CY2023Q2	us-gaap	Assets Assets	95319064	usd
CY2022Q2	us-gaap	Assets Assets	101880795	usd
CY2023Q2	us-gaap	Debt Current DebtCurrent	10554617	usd
CY2022Q2	us-gaap	Debt Current DebtCurrent	14474363	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	690035	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	343597	usd
CY2023Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	324021	usd
CY2022Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	352402	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	2503375	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	2355066	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	918470	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	587140	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	10586239	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12203933	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	712302	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	24889	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	66884	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	26313948	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	30383385	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	104114	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	185382	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	150547	usd
CY2023Q2	clps	Unrecognized Taxs Benefit UnrecognizedTaxsBenefit	2320918	usd
CY2022Q2	clps	Unrecognized Taxs Benefit UnrecognizedTaxsBenefit	2587194	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	885901	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	959069	usd
CY2023Q2	us-gaap	Liabilities Liabilities	29810263	usd
CY2022Q2	us-gaap	Liabilities Liabilities	34080195	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23650122	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23650122	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22444822	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22444822	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	2365	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	2244	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	58183383	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	55705209	usd
CY2023Q2	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	5356828	usd
CY2022Q2	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	5071876	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	5029021	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6323792	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3990594	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-550248	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	64581003	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	66552873	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	927798	usd
CY2022Q2	us-gaap	Minority Interest MinorityInterest	1247727	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	65508801	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	67800600	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	95319064	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	101880795	usd
CY2023	us-gaap	Revenues Revenues	150356539	usd
CY2022	us-gaap	Revenues Revenues	152022381	usd
CY2021	us-gaap	Revenues Revenues	126061693	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	115874809	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	111033345	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	85890757	usd
CY2023	us-gaap	Gross Profit GrossProfit	34481730	usd
CY2022	us-gaap	Gross Profit GrossProfit	40989036	usd
CY2021	us-gaap	Gross Profit GrossProfit	40170936	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3300555	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4103066	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3753236	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8336999	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7971145	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13337913	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	21641317	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23045664	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16784688	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2382538	usd
CY2023	clps	Vat Refunds And Government Subsidies VATRefundsAndGovernmentSubsidies	-1256070	usd
CY2022	clps	Vat Refunds And Government Subsidies VATRefundsAndGovernmentSubsidies	-1536394	usd
CY2021	clps	Vat Refunds And Government Subsidies VATRefundsAndGovernmentSubsidies	-2080087	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	34405339	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	33583481	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	31795750	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	76391	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	7405555	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	8375186	usd
CY2023	us-gaap	Other Income OtherIncome	1123612	usd
CY2022	us-gaap	Other Income OtherIncome	854250	usd
CY2021	us-gaap	Other Income OtherIncome	296319	usd
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	430357	usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	575605	usd
CY2021	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	351045	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	769646	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7684200	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	8320460	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	674344	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3045992	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1257124	usd
CY2023	clps	Loss Income Before Share Of Loss In Equity Investees LossIncomeBeforeShareOfLossInEquityInvestees	95302	usd
CY2022	clps	Loss Income Before Share Of Loss In Equity Investees LossIncomeBeforeShareOfLossInEquityInvestees	4638208	usd
CY2021	clps	Loss Income Before Share Of Loss In Equity Investees LossIncomeBeforeShareOfLossInEquityInvestees	7063336	usd
CY2023	clps	Share Of Loss In Equity Investees Net Of Tax ShareOfLossInEquityInvesteesNetOfTax	70263	usd
CY2022	clps	Share Of Loss In Equity Investees Net Of Tax ShareOfLossInEquityInvesteesNetOfTax	-50297	usd
CY2021	clps	Share Of Loss In Equity Investees Net Of Tax ShareOfLossInEquityInvesteesNetOfTax	-44121	usd
CY2023	us-gaap	Profit Loss ProfitLoss	165565	usd
CY2022	us-gaap	Profit Loss ProfitLoss	4587911	usd
CY2021	us-gaap	Profit Loss ProfitLoss	7019215	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-26964	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	132483	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	202643	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	192529	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	4455428	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	6816572	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3532507	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1828542	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2695223	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-92161	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-48211	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	102475	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3440346	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1780331	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2592748	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3247817	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	2675097	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	9409320	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	119125	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-84272	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-305118	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3366942	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2759369	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9714438	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.01
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.21
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.39
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23153976	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20924683	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17279443	shares
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.01
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.21
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.39
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23153976	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21057063	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17569440	shares
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	28617360	usd
CY2021	us-gaap	Profit Loss ProfitLoss	7019215	usd
CY2021	clps	Foreign Currency Translation Adjustments ForeignCurrencyTranslationAdjustments	2695223	usd
CY2021	clps	Purchase Of Subsidiaries Shares From Noncontrolling Interests Shareholders PurchaseOfSubsidiariesSharesFromNoncontrollingInterestsShareholders	-455546	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-34116	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	5128696	usd
CY2021	clps	Exercise Of Share Options And Vesting Of Restricted Shares ExerciseOfShareOptionsAndVestingOfRestrictedShares	116230	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	11131829	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	3551048	usd
CY2021	clps	Stock Issue During Period Value Nci Through Acquisition StockIssueDuringPeriodValueNciThroughAcquisition	-5107	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	34137	usd
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	57730695	usd
CY2022	us-gaap	Profit Loss ProfitLoss	4587911	usd
CY2022	clps	Foreign Currency Translation Adjustments ForeignCurrencyTranslationAdjustments	-1828542	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	7184862	usd
CY2022	clps	Exercise Of Share Options And Vesting Of Restricted Shares ExerciseOfShareOptionsAndVestingOfRestrictedShares	3867	usd
CY2022	clps	Stock Issue During Period Value Nci Through Acquisition StockIssueDuringPeriodValueNciThroughAcquisition	121807	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	67800600	usd
CY2023	clps	Cumulative Effect Of Accounting Change CumulativeEffectOfAccountingChange	26664	usd
CY2023	us-gaap	Profit Loss ProfitLoss	165565	usd
CY2023	clps	Foreign Currency Translation Adjustments ForeignCurrencyTranslationAdjustments	-3532507	usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	6283	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2478295	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	207087	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	1175684	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	65508801	usd
CY2023	us-gaap	Profit Loss ProfitLoss	165565	usd
CY2022	us-gaap	Profit Loss ProfitLoss	4587911	usd
CY2021	us-gaap	Profit Loss ProfitLoss	7019215	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2478295	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	7184862	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	5128696	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1219812	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	912248	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	677241	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	264027	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	245830	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-413609	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1070385	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	138479	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	70263	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-50297	usd
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-44121	usd
CY2023	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	-38674	usd
CY2021	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	9022	usd
CY2023	us-gaap	Provision For Other Losses ProvisionForOtherLosses	-10525	usd
CY2022	us-gaap	Provision For Other Losses ProvisionForOtherLosses	-178010	usd
CY2021	us-gaap	Provision For Other Losses ProvisionForOtherLosses	197740	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-19188	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-26399	usd
CY2023	us-gaap	Impairment Of Investments ImpairmentOfInvestments	85326	usd
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	102155	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2382538	usd
CY2023	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-258262	usd
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	25615	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-454071	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12317416	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16712597	usd
CY2023	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-3457373	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	123268	usd
CY2021	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	728562	usd
CY2021	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-15780	usd
CY2023	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-27836	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-222553	usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	224429	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	346438	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-215853	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	363697	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3850	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	106994	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-18349	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	331330	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	260228	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-378628	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	148309	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	640057	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	279413	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-291087	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-115260	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	183148	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-769939	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	174100	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	309914	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1101526	usd
CY2023	clps	Increase Decrease In Unrecognized Tax Benefit IncreaseDecreaseInUnrecognizedTaxBenefit	-266276	usd
CY2022	clps	Increase Decrease In Unrecognized Tax Benefit IncreaseDecreaseInUnrecognizedTaxBenefit	1782752	usd
CY2021	clps	Increase Decrease In Unrecognized Tax Benefit IncreaseDecreaseInUnrecognizedTaxBenefit	1604444	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9705951	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3200889	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2609773	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	519282	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20750110	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1072389	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	158365	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	552	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	9076	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	6521	usd
CY2021	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	304476	usd
CY2022	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	409625	usd
CY2021	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	331036	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	1619792	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	676179	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	1746327	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	365893	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	342144	usd
CY2023	clps	Disposition Of Longterm Investment DispositionOfLongtermInvestment	-111066	usd
CY2022	clps	Disposition Of Longterm Investment DispositionOfLongtermInvestment	-786427	usd
CY2023	clps	Disposition Of Subsidiaries DispositionOfSubsidiaries	-13806	usd
CY2021	clps	Disposition Of Subsidiaries DispositionOfSubsidiaries	191839	usd
CY2023	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	14130000	usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	14130000	usd
CY2022	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-4159309	usd
CY2021	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	3375521	usd
CY2023	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	204211	usd
CY2022	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	15491	usd
CY2021	clps	Loans Provided To Infogain LoansProvidedToInfogain	185906	usd
CY2023	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	274212	usd
CY2022	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	83651	usd
CY2021	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	151783	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-306046	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16290683	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5619471	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	23388911	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	21955625	usd
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	13301775	usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	26325471	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	14484851	usd
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	8270611	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	14682877	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3867	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	116230	usd
CY2021	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-455546	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1175684	usd
CY2023	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	207087	usd
CY2021	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	34137	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4319331	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7474641	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19340588	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1175928	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-727242	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	975918	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3904646	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6342395	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	12087262	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18396987	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24739382	usd
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12652120	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22301633	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18396987	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	154516	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24739382	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22214029	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18396987	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24739382	usd
CY2023Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	87604	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22301633	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18396987	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24739382	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Use of estimates and assumptions</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing the consolidated financial statements in conformity with U.S. GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information as of the date of the consolidated financial statements. Significant estimates required to be made by management include, but are not limited to, allowance for doubtful accounts arising from expected credit losses, useful lives of property and equipment and intangible assets, goodwill impairment, the impairment of long-lived assets and long-term investments, purchase price allocation and fair value of noncontrolling interests for business combinations and asset acquisition, provision for accrued expenses and other current liabilities, valuation allowance of deferred tax assets, provision for uncertain tax positions, incremental borrowing rates for operating lease liabilities, fair value measurements of equity investments without readily determinable fair values, fair value of warrants and fair value of and estimated forfeitures for share-based compensation. Actual results could differ from those estimates.</p>
CY2022Q3	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	26664	usd
CY2023	clps	Percentage Of Goodwill PercentageOfGoodwill	1	pure
CY2022	clps	Percentage Of Goodwill PercentageOfGoodwill	1	pure
CY2023	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax	2382538	usd
CY2023Q2	clps	Contract Assets ContractAssets	1461411	usd
CY2023Q2	clps	Contract Assets Current ContractAssetsCurrent	691025	usd
CY2023Q2	clps	Closing Balance Of Contract Liabilities ClosingBalanceOfContractLiabilities	587140	usd
CY2023	clps	Closing Balance Of Contract Liabilities Current ClosingBalanceOfContractLiabilitiesCurrent	918470	usd
CY2023	clps	Revenue Recognized Contract Liabilities Beginning Balance RevenueRecognizedContractLiabilitiesBeginningBalance	560256	usd
CY2023	clps	Percentage Of Value Added Tax PercentageOfValueAddedTax	0.06	pure
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4215414	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4214414	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1607044	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	928675	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	710602	usd
CY2022Q2	clps	Accrued Expenses And Other Liabilities AccruedExpensesAndOtherLiabilities	352402	usd
CY2022Q3	clps	Accrued Expenses And Other Liabilities AccruedExpensesAndOtherLiabilities	319169	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	815324	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	712302	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	104114	usd
CY2023Q2	clps	Accrued Expenses And Other Liabilities AccruedExpensesAndOtherLiabilities	324021	usd
CY2021	us-gaap	Other Expenses OtherExpenses	6180287	usd
CY2022	us-gaap	Other Expenses OtherExpenses	16771118	usd
CY2023	us-gaap	Other Expenses OtherExpenses	18025748	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.50	pure
CY2023	clps	Income Tax Examination Yearunder Examination IncomeTaxExaminationYearunderExamination	P10Y
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">Concentrations and risks</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">- Foreign currency risk</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A majority of the transactions of the Company’s PRC subsidiaries are denominated in Renminbi (“RMB”) and a significant portion of the Company and its subsidiaries’ assets and liabilities are denominated in RMB. RMB is not freely convertible into foreign currencies. In the PRC, certain foreign exchange transactions are required by law to be transacted only by authorized financial institutions at exchange rates as set forth in the H.10 statistical release of the U.S. Federal Reserve Board. Remittances in currencies other than RMB by the Company in China must be processed through the People’s Bank of China (“PBOC”) or other China foreign exchange regulatory bodies which require certain supporting documentation in order to affect the remittance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.7pt; text-align: justify">The functional currency for the Company’s PRC subsidiaries is the RMB, and the financial statements are presented in U.S. dollars. The RMB appreciated by 8.6% in fiscal 2021, depreciated by 3.7% in fiscal 2022, and depreciated by 8.3% in fiscal 2023, respectively. It is difficult to predict how market forces or PRC or U.S. government policy may impact the exchange rate between the RMB and the U.S. dollar in the future. The change in the value of the RMB relative to the U.S. dollar may affect the Company’s financial results reported in the U.S. dollar terms without giving effect to any underlying changes in its business or results of operations. Currently, the majority of the Company’s assets, liabilities, revenues and costs are denominated in RMB.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent that the Company needs to convert U.S. dollars into RMB for capital expenditures and working capital and other business purposes, appreciation of RMB against U.S. dollar would have an adverse effect on the RMB amount the Company would receive from the conversion. Conversely, if the Company decides to convert RMB into U.S. dollar for the purpose of making payments for dividends, strategic acquisition or investments or other business purposes, appreciation of U.S. dollar against RMB would have a negative effect on the U.S. dollar amount available to the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">- Concentration of credit risk</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents, account receivables, other assets, note receivables, and amounts due from related parties. As of June 30, 2023 and 2022, US$17,809,090 and US$14,787,554 of the Company’s cash and cash equivalents was on deposit at financial institutions in the PRC where there currently is no rule or regulation requiring such financial institutions to maintain insurance to cover bank deposits in the event of bank failure. As of June 30, 2023, the Company and its subsidiaries had US$17,809,090, US$1,289,130, US$13,543, US$2,832,122, US$ 90,180, US$32,368, US$34,921, US$120,953 and US$79,326 of cash and cash equivalents on deposit at financial institutions in mainland China, Singapore, Australia, Hong Kong, Malaysia, India, Japan, America and Philippines, respectively. As of June 30, 2022, the Company and its subsidiaries had US$14,787,554, US$2,034,692, US$6,800, US$1,195,402, US$6,799, US$4,007, US$75,322, US$24,583 and US$91,828 of cash and cash equivalents on deposit at financial institutions in mainland China, Singapore, Australia, Hong Kong, Malaysia, India, Japan, America and Philippines, respectively. The Company continues to monitor the financial strength of the financial institutions. There has been no recent history of default in relation to these financial institutions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company conducts credit evaluations on its customers and generally does not require collateral or other security from such customers. The Company periodically evaluates the creditworthiness of the existing customers in determining an allowance for doubtful accounts primarily based upon the age of the receivables and factors surrounding the credit risk of specific customers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">- Significant customers</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The top two customers and their affiliates accounted for 21.4%, and 9.4%, respectively, of total revenues during the year ended June 30, 2023, 20.6%, and 12.2%, respectively, of total revenues during the year ended June 30, 2022. The top two customers and their affiliates accounted for 19.1%, and 11.9%, respectively, of total revenues during the year ended June 30, 2021. The top two customers accounted for 32.3%, and 4.1%, respectively, of the Company’s total accounts receivable balance as of June 30, 2023, 30.2%, and 9.3%, respectively, of the Company’s total accounts receivable balance as of June 30, 2022.</p>
CY2022	clps	Currency Deprecated Percentage CurrencyDeprecatedPercentage	0.037	pure
CY2023	clps	Currency Deprecated Percentage CurrencyDeprecatedPercentage	0.083	pure
CY2021Q1	clps	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Previous Held Equity Interest BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPreviousHeldEquityInterest	308975	usd
CY2021Q1	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	289980	usd
CY2021Q1	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	1880000	cny
CY2021Q1	clps	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Useful Life BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedUsefulLife	P5Y
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	48582555	usd
CY2022Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	53896259	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	67088	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	126372	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	48515467	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	53769887	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	126372	usd
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	309076	usd
CY2023	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	13372	usd
CY2023	clps	Provision For Doubtful Accounts Receivable Current ProvisionForDoubtfulAccountsReceivableCurrent	11238	usd
CY2022	clps	Provision For Doubtful Accounts Receivable Current ProvisionForDoubtfulAccountsReceivableCurrent	2508	usd
CY2023	clps	Recovery Of Doubtful Account RecoveryOfDoubtfulAccount	15788	usd
CY2022	clps	Recovery Of Doubtful Account RecoveryOfDoubtfulAccount	180518	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	67599	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	507	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	4694	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	67088	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	126372	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	970044	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	179078	usd
CY2023Q2	clps	Contract Asset ContractAsset	691025	usd
CY2022Q2	clps	Contract Asset ContractAsset	1461411	usd
CY2023Q2	clps	Advances And Deposits To Suppliers AdvancesAndDepositsToSuppliers	155179	usd
CY2022Q2	clps	Advances And Deposits To Suppliers AdvancesAndDepositsToSuppliers	728238	usd
CY2023Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	114400	usd
CY2022Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	714127	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	280223	usd
CY2022Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	187916	usd
CY2023Q2	clps	Advances To Employees AdvancesToEmployees	100090	usd
CY2022Q2	clps	Advances To Employees AdvancesToEmployees	6865	usd
CY2022Q2	clps	Government Subsidies GovernmentSubsidies	437288	usd
CY2023Q2	us-gaap	Prepaid Taxes PrepaidTaxes	74329	usd
CY2023Q2	clps	Allowance For Doubtful Accounts Prepaid Expenses And Other Assets Current AllowanceForDoubtfulAccountsPrepaidExpensesAndOtherAssetsCurrent	7316	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1918392	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	4463870	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	252656	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	248456	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1665736	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4215414	usd
CY2023	clps	Allowance For Doubtful Accounts Receivable Adoption AllowanceForDoubtfulAccountsReceivableAdoption	13292	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	5976	usd
CY2023Q2	clps	Allowance For Doubtful Accounts Prepaid Expense And Other Assets Current AllowanceForDoubtfulAccountsPrepaidExpenseAndOtherAssetsCurrent	7316	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Goodwill1 DisposalGroupIncludingDiscontinuedOperationGoodwill1	74686	usd
CY2023	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	9895	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	726175	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22550672	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	22504182	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2438367	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1903084	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20112305	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20601098	usd
CY2023	us-gaap	Depreciation Depreciation	1040734	usd
CY2022	us-gaap	Depreciation Depreciation	709836	usd
CY2021	us-gaap	Depreciation Depreciation	404063	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	421158	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	624321	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	726175	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	970044	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	179078	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	202412	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	273178	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	121050	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	116823	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	109954	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	107628	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	107493	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	163227	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	726175	usd
CY2022Q2	us-gaap	Goodwill Goodwill	2363841	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2382538	usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	18697	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	2382538	usd
CY2023Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P4Y
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1070385	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1101526	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	815324	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M15D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0554	pure
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	783669	usd
CY2023	us-gaap	Selling Expense SellingExpense	263775	usd
CY2023	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	55082	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	942606	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	1413521	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	733982	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	105063	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	839045	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	22629	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	816416	usd
CY2021Q1	us-gaap	Cash Cash	83228	usd
CY2021Q1	us-gaap	Cash Cash	540000	cny
CY2021Q3	us-gaap	Cash Cash	157464	usd
CY2021Q3	us-gaap	Cash Cash	1200000	hkd
CY2022	us-gaap	Impairment Of Investments ImpairmentOfInvestments	102155	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1550145	usd
CY2023Q2	clps	Loan From Bank Of Shanghai Pudong Development LoanFromBankOfShanghaiPudongDevelopment	5683626	usd
CY2022Q2	clps	Loan From Bank Of Shanghai Pudong Development LoanFromBankOfShanghaiPudongDevelopment	7040738	usd
CY2023Q2	clps	Loans Payable To Bank One LoansPayableToBankOne	3491928	usd
CY2022Q2	clps	Loans Payable To Bank One LoansPayableToBankOne	5931331	usd
CY2023Q2	us-gaap	Loans Payable To Bank LoansPayableToBank	1379063	usd
CY2022Q2	us-gaap	Loans Payable To Bank LoansPayableToBank	1492961	usd
CY2022Q2	clps	Loans Payable To Bank Two LoansPayableToBankTwo	9333	usd
CY2023Q2	us-gaap	Debt Current DebtCurrent	10554617	usd
CY2022Q2	us-gaap	Debt Current DebtCurrent	14474363	usd
CY2023Q2	clps	Short Term Debt ShortTermDebt	10554617	usd
CY2022Q2	clps	Short Term Debt ShortTermDebt	14474363	usd
CY2023	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	10000000	cny
CY2023	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	10000000	cny
CY2023	us-gaap	Proceeds From Federal Home Loan Bank Borrowings ProceedsFromFederalHomeLoanBankBorrowings	58000000	hkd
CY2023Q2	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	58000000	hkd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	365893	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	447187	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	156749	usd
CY2023Q2	us-gaap	Weighted Average Interest Rate On Overdrawn Demand Deposit WeightedAverageInterestRateOnOverdrawnDemandDeposit	0.03467	pure
CY2022Q2	us-gaap	Weighted Average Interest Rate On Overdrawn Demand Deposit WeightedAverageInterestRateOnOverdrawnDemandDeposit	0.03771	pure
CY2021Q2	us-gaap	Weighted Average Interest Rate On Overdrawn Demand Deposit WeightedAverageInterestRateOnOverdrawnDemandDeposit	0.0416	pure
CY2023	clps	Loan Principal Due Year LoanPrincipalDueYear	P1Y
CY2023	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1181491	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.15	pure
CY2023	clps	Preferential Tax Rate PreferentialTaxRate	0.15	pure
CY2023	clps	Statutory Income Tax Rate StatutoryIncomeTaxRate	0.15	pure
CY2023	clps	Reduced Eit Rate ReducedEITRate	0.15	pure
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	4350067	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	17366634	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	14814221	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-3580421	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-9682434	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-6493761	usd
CY2023	clps	Incomeloss Before Income Taxes Total IncomelossBeforeIncomeTaxesTotal	769646	usd
CY2022	clps	Incomeloss Before Income Taxes Total IncomelossBeforeIncomeTaxesTotal	7684200	usd
CY2021	clps	Incomeloss Before Income Taxes Total IncomelossBeforeIncomeTaxesTotal	8320460	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2023	clps	Effect Of Income Tax Rate Difference Inother Jurisdictions EffectOfIncomeTaxRateDifferenceInotherJurisdictions	1.155	pure
CY2022	clps	Effect Of Income Tax Rate Difference Inother Jurisdictions EffectOfIncomeTaxRateDifferenceInotherJurisdictions	0.258	pure
CY2021	clps	Effect Of Income Tax Rate Difference Inother Jurisdictions EffectOfIncomeTaxRateDifferenceInotherJurisdictions	0.191	pure
CY2023	clps	Effective Income Tax Rate Reconciliation Deferred Tax EffectiveIncomeTaxRateReconciliationDeferredTax	0.079	pure
CY2022	clps	Effective Income Tax Rate Reconciliation Deferred Tax EffectiveIncomeTaxRateReconciliationDeferredTax	-0.003	pure
CY2021	clps	Effective Income Tax Rate Reconciliation Deferred Tax EffectiveIncomeTaxRateReconciliationDeferredTax	-0.005	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Holidays EffectiveIncomeTaxRateReconciliationTaxHolidays	0.285	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Holidays EffectiveIncomeTaxRateReconciliationTaxHolidays	0.101	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Holidays EffectiveIncomeTaxRateReconciliationTaxHolidays	0.053	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	-0.051	pure
CY2023	clps	Effective Income Tax Rate Reconciliation Tax Credits Research And Development EffectiveIncomeTaxRateReconciliationTaxCreditsResearchAndDevelopment	-2.304	pure
CY2022	clps	Effective Income Tax Rate Reconciliation Tax Credits Research And Development EffectiveIncomeTaxRateReconciliationTaxCreditsResearchAndDevelopment	-0.18	pure
CY2021	clps	Effective Income Tax Rate Reconciliation Tax Credits Research And Development EffectiveIncomeTaxRateReconciliationTaxCreditsResearchAndDevelopment	-0.289	pure
CY2023	clps	Effective Income Tax Rate Reconciliation Business Insurancein Dollars EffectiveIncomeTaxRateReconciliationBusinessInsuranceinDollars	0.137	pure
CY2022	clps	Effective Income Tax Rate Reconciliation Business Insurancein Dollars EffectiveIncomeTaxRateReconciliationBusinessInsuranceinDollars	0.015	pure
CY2021	clps	Effective Income Tax Rate Reconciliation Business Insurancein Dollars EffectiveIncomeTaxRateReconciliationBusinessInsuranceinDollars	0.013	pure
CY2023	clps	Effective Income Tax Rate Reconciliation Late Payment Interestin Dollars EffectiveIncomeTaxRateReconciliationLatePaymentInterestinDollars	0.425	pure
CY2022	clps	Effective Income Tax Rate Reconciliation Late Payment Interestin Dollars EffectiveIncomeTaxRateReconciliationLatePaymentInterestinDollars	0.005	pure
CY2021	clps	Effective Income Tax Rate Reconciliation Late Payment Interestin Dollars EffectiveIncomeTaxRateReconciliationLatePaymentInterestinDollars	0.006	pure
CY2023	clps	Withholding Tax WithholdingTax	0.091	pure
CY2021	clps	Withholding Tax WithholdingTax	0.117	pure
CY2023	clps	Effective Income Tax Rate Reconciliation At Depreciation And Amortization Rate EffectiveIncomeTaxRateReconciliationAtDepreciationAndAmortizationRate	0.075	pure
CY2022	clps	Effective Income Tax Rate Reconciliation At Depreciation And Amortization Rate EffectiveIncomeTaxRateReconciliationAtDepreciationAndAmortizationRate	0.004	pure
CY2021	clps	Effective Income Tax Rate Reconciliation At Depreciation And Amortization Rate EffectiveIncomeTaxRateReconciliationAtDepreciationAndAmortizationRate	-0.002	pure
CY2023	clps	Investment Gainloss InvestmentGainloss	0.432	pure
CY2022	clps	Investment Gainloss InvestmentGainloss	-0.015	pure
CY2021	clps	Investment Gainloss InvestmentGainloss	-0.001	pure
CY2023	clps	Effective Income Tax Rate Reconciliation At Statutory Incomeexpense EffectiveIncomeTaxRateReconciliationAtStatutoryIncomeexpense	-0.061	pure
CY2022	clps	Effective Income Tax Rate Reconciliation At Statutory Incomeexpense EffectiveIncomeTaxRateReconciliationAtStatutoryIncomeexpense	-0.014	pure
CY2021	clps	Effective Income Tax Rate Reconciliation At Statutory Incomeexpense EffectiveIncomeTaxRateReconciliationAtStatutoryIncomeexpense	0.016	pure
CY2023	clps	Transfer Pricing Adjustment TransferPricingAdjustment	-0.247	pure
CY2022	clps	Transfer Pricing Adjustment TransferPricingAdjustment	0.108	pure
CY2021	clps	Transfer Pricing Adjustment TransferPricingAdjustment	0.075	pure
CY2021	clps	Effective Income Tax Rate Reconciliation Tax Credits Deferred Tax EffectiveIncomeTaxRateReconciliationTaxCreditsDeferredTax	0.003	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.433	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.066	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.167	pure
CY2023	clps	Goodwill Provision Tax Rate GoodwillProvisionTaxRate	0.69	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.058	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.005	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.003	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.877	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.398	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.151	pure
CY2022Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	150547	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	70016	usd
CY2021Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	994941	usd
CY2023Q2	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	23459996	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	410317	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2800162	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1670733	usd
CY2023	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	264027	usd
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	245830	usd
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-413609	usd
CY2023	us-gaap	Discontinued Operation Tax Expense Benefit From Provision For Gain Loss On Disposal DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal	674344	usd
CY2022	us-gaap	Discontinued Operation Tax Expense Benefit From Provision For Gain Loss On Disposal DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal	3045992	usd
CY2021	us-gaap	Discontinued Operation Tax Expense Benefit From Provision For Gain Loss On Disposal DiscontinuedOperationTaxExpenseBenefitFromProvisionForGainLossOnDisposal	1257124	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	996177	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	743898	usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	39516	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	163497	usd
CY2023Q2	us-gaap	Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction	169375	usd
CY2023Q2	clps	Share Of Investees Loss ShareOfInvesteesLoss	27078	usd
CY2022Q2	clps	Share Of Investees Loss ShareOfInvesteesLoss	129191	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	28724	usd
CY2022Q2	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	71714	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1009596	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	781260	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	251274	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	327040	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	169375	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	117781	usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	150547	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	67601	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	354757	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	150547	usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	81899	usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	327040	usd
CY2023Q2	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	185382	usd
CY2022Q2	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	23731272	usd
CY2023	clps	Unrecognized Tax Benefit UnrecognizedTaxBenefit	2442085	usd
CY2022	clps	Unrecognized Tax Benefit UnrecognizedTaxBenefit	3095554	usd
CY2021	clps	Unrecognized Tax Benefit UnrecognizedTaxBenefit	1333608	usd
CY2023Q2	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	1924305	usd
CY2022Q2	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	2497005	usd
CY2021Q2	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	1750616	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	21256	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	446490	usd
CY2021Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	208109	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3095554	usd
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1333608	usd
CY2020Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	194939	usd
CY2023	clps	Increases In Unrecognized Tax Benefit IncreasesInUnrecognizedTaxBenefit	934563	usd
CY2022	clps	Increases In Unrecognized Tax Benefit IncreasesInUnrecognizedTaxBenefit	2132154	usd
CY2021	clps	Increases In Unrecognized Tax Benefit IncreasesInUnrecognizedTaxBenefit	1139596	usd
CY2023	clps	Decrease Unrecognized Tax Benefit DecreaseUnrecognizedTaxBenefit	-1386797	usd
CY2022	clps	Decrease Unrecognized Tax Benefit DecreaseUnrecognizedTaxBenefit	-267622	usd
CY2021	clps	Decrease Unrecognized Tax Benefit DecreaseUnrecognizedTaxBenefit	-47149	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-201235	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-102586	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	46222	usd
CY2023Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2442085	usd
CY2022Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3095554	usd
CY2021Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1333608	usd
CY2023Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	654799	usd
CY2022Q2	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	693239	usd
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	417445	usd
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	462792	usd
CY2023Q2	clps	Withholding Tax Payable WithholdingTaxPayable	343753	usd
CY2022Q2	clps	Withholding Tax Payable WithholdingTaxPayable	349582	usd
CY2023Q2	clps	Disability Insurance Fund Payable DisabilityInsuranceFundPayable	1011958	usd
CY2022Q2	clps	Disability Insurance Fund Payable DisabilityInsuranceFundPayable	776979	usd
CY2023Q2	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	75420	usd
CY2022Q2	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	72474	usd
CY2023Q2	clps	Taxe Payable Current TaxePayableCurrent	2503375	usd
CY2022Q2	clps	Taxe Payable Current TaxePayableCurrent	2355066	usd
CY2022Q2	clps	Stockholder Equity Including Portion Attributable To Noncontrolling Interest StockholderEquityIncludingPortionAttributableToNoncontrollingInterest	-550248	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	192529	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4455428	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6816572	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23153976	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20924683	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17279443	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	192529	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	4455428	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	6816572	usd
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	23153976	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	20924683	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	17279443	shares
CY2021	clps	Share Options ShareOptions	179479	shares
CY2022	clps	Earnings Loss Share Rs Us EarningsLossShareRSUs	132380	usd
CY2021	clps	Earnings Loss Share Rs Us EarningsLossShareRSUs	110518	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23153976	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21057063	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17569440	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2023	clps	Other Comprehensive Loss Before Reclassification OtherComprehensiveLossBeforeReclassification	3532507	usd
CY2021Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	2666666	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2666666	shares
CY2022Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2666666	shares
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.4148	pure
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0083	pure
CY2021Q1	clps	Public Offering Warrants PublicOfferingWarrants	3413332	usd
CY2023	clps	Share Based Compensation Cost ShareBasedCompensationCost	1000105	usd
CY2022	clps	Share Based Compensation Cost ShareBasedCompensationCost	1196971	usd
CY2021	clps	Share Based Compensation Cost ShareBasedCompensationCost	529479	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.43	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.40	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.41	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.04	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0036	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023Q2	clps	Fair Market Value Per Common Share FairMarketValuePerCommonShare	1.135	usd
CY2021Q2	clps	Fair Market Value Per Common Share FairMarketValuePerCommonShare	2.89	usd
CY2022	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	48211	usd
CY2022	clps	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Intrinsic Value Total ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodIntrinsicValueTotal	1125	usd
CY2021	clps	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Intrinsic Value Total ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodIntrinsicValueTotal	57613	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1152356	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	505295	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	354701	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	682436	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y7M9D
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	2519600	shares
CY2023	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	1161000	shares
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2478295	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	7184862	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	5128696	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.05
CY2023Q1	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	1180000	usd
CY2023	clps	Statutory Reserve Description StatutoryReserveDescription	In addition, the Company’s subsidiaries incorporated in the PRC are required to annually appropriate 10% of their net income to the statutory reserve prior to payment of any dividends, unless the reserve has reached 50% of their respective registered capital.
CY2021Q2	clps	Stockholder Equity Including Portion Attributable To Noncontrolling Interest StockholderEquityIncludingPortionAttributableToNoncontrollingInterest	1230083	usd
CY2022	clps	Other Comprehensive Loss Before Reclassification OtherComprehensiveLossBeforeReclassification	1828542	usd
CY2022	clps	Net Currentperiod Other Comprehensive Income NetCurrentperiodOtherComprehensiveIncome	1828542	usd
CY2023	clps	Net Currentperiod Other Comprehensive Income NetCurrentperiodOtherComprehensiveIncome	3532507	usd
CY2023	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest	92161	usd
CY2023Q2	clps	Stockholder Equity Including Portion Attributable To Noncontrolling Interest StockholderEquityIncludingPortionAttributableToNoncontrollingInterest	-3990594	usd
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	278000	usd
CY2019Q4	clps	Noncontrolling Equity Interest NoncontrollingEquityInterest	1	pure
CY2019Q4	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	130992	usd
CY2019Q4	clps	Purchase Consideration And Carryinng Value PurchaseConsiderationAndCarryinngValue	131002	usd
CY2020Q4	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.80	pure
CY2020Q4	clps	Noncontrolling Equity Interest NoncontrollingEquityInterest	0.20	pure
CY2020Q4	clps	Purchase Consideration PurchaseConsideration	621619	usd
CY2020Q4	us-gaap	Other Investments OtherInvestments	436550	usd
CY2020Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	62622	shares
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	185069	usd
CY2021Q1	clps	Market Price Per Share MarketPricePerShare	3.41
CY2021Q1	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	446636	usd
CY2021Q1	clps	Purchase Consideration And Carryinng Value PurchaseConsiderationAndCarryinngValue	10080	usd
CY2023	us-gaap	Minority Interest Description MinorityInterestDescription	Prior to January 2021, JAJI China, a 60% owned subsidiary of CLPS, owned 70% of JAJI HR. In January 2021, JAJI China entered into an agreement with CareerWin to purchase CareerWin’s 30% equity interest in JAJI HR. After the transaction, JAJI China owned 100% of JAJI HR. The purchase consideration was $18,995. The carrying amount of the noncontrolling interests was $12,189. The transaction was accounted for as an equity transaction and the difference of $6,806 between the purchase consideration and the carrying value of the noncontrolling interest of JAJI HR was recorded in the additional paid-in capital on the consolidated balance sheets.
CY2021Q2	us-gaap	Minority Interest MinorityInterest	53.33	usd
CY2021Q2	clps	Purchase Consideration PurchaseConsideration	205711	usd
CY2021Q2	us-gaap	Redeemable Noncontrolling Interest Equity Common Carrying Amount RedeemableNoncontrollingInterestEquityCommonCarryingAmount	121807	usd
CY2023	clps	Equity Interests EquityInterests	0.60	pure
CY2023	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	6283	usd
CY2023	us-gaap	Revenues Revenues	150356539	usd
CY2022	us-gaap	Revenues Revenues	152022381	usd
CY2021	us-gaap	Revenues Revenues	126061693	usd
CY2023	us-gaap	Revenues Revenues	150356539	usd
CY2022	us-gaap	Revenues Revenues	152022381	usd
CY2021	us-gaap	Revenues Revenues	126061693	usd
CY2023Q2	clps	Longlivedassets Longlivedassets	20112305	usd
CY2022Q2	clps	Longlivedassets Longlivedassets	20601098	usd
CY2023Q2	us-gaap	Goodwill Goodwill		usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2021	clps	Appropriation Of Statutory Reserve AppropriationOfStatutoryReserve		usd
CY2021	clps	Exercise Of Warrants Value ExerciseOfWarrantsValue		usd
CY2022	clps	Appropriation Of Statutory Reserve AppropriationOfStatutoryReserve		usd
CY2022	clps	Stock Surrender During The Period Of Shares StockSurrenderDuringThePeriodOfShares		usd
CY2023	clps	Appropriation Of Statutory Reserve AppropriationOfStatutoryReserve		usd
CY2023	clps	Exercise Of Share Options And Vesting Of Restricted Shares ExerciseOfShareOptionsAndVestingOfRestrictedShares		usd
CY2023	clps	Stock Issue During Period Value Nci Through Acquisition StockIssueDuringPeriodValueNciThroughAcquisition		usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2022	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary		usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2021	us-gaap	Impairment Of Investments ImpairmentOfInvestments		usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement		usd
CY2023	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes		usd
CY2022	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes		usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses		usd
CY2022	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses		usd
CY2023	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments		usd
CY2021	clps	Disposition Of Longterm Investment DispositionOfLongtermInvestment		usd
CY2022	clps	Disposition Of Subsidiaries DispositionOfSubsidiaries		usd
CY2022	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		usd
CY2021	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
CY2023	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments		usd
CY2021	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties		usd
CY2023	clps	Loans Provided To Infogain LoansProvidedToInfogain		usd
CY2022	clps	Loans Provided To Infogain LoansProvidedToInfogain		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2023	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders		usd
CY2022	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders		usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock		usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock		usd
CY2022	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest		usd
CY2022Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents		usd
CY2021Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents		usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax		usd
CY2021	us-gaap	Goodwill Impairment Loss Net Of Tax GoodwillImpairmentLossNetOfTax		usd
CY2022	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings		usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		usd
CY2023Q2	clps	Government Subsidies GovernmentSubsidies		usd
CY2022Q2	us-gaap	Prepaid Taxes PrepaidTaxes		usd
CY2022Q2	clps	Allowance For Doubtful Accounts Prepaid Expenses And Other Assets Current AllowanceForDoubtfulAccountsPrepaidExpensesAndOtherAssetsCurrent		usd
CY2022Q2	clps	Allowance For Doubtful Accounts Prepaid Expense And Other Assets Current AllowanceForDoubtfulAccountsPrepaidExpenseAndOtherAssetsCurrent		usd
CY2021Q2	clps	Allowance For Doubtful Accounts Prepaid Expense And Other Assets Current AllowanceForDoubtfulAccountsPrepaidExpenseAndOtherAssetsCurrent		usd
CY2022	clps	Allowance For Doubtful Accounts Receivable Adoption AllowanceForDoubtfulAccountsReceivableAdoption		usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries		usd
CY2022Q2	clps	Allowance For Doubtful Accounts Prepaid Expense And Other Assets Current AllowanceForDoubtfulAccountsPrepaidExpenseAndOtherAssetsCurrent		usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	5800000	hkd
CY2023	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1		usd
CY2023Q2	us-gaap	Goodwill Goodwill		usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive		usd
CY2023Q2	clps	Lessee Operating Lease Liability Minimum Payments Related To Leases LesseeOperatingLeaseLiabilityMinimumPaymentsRelatedToLeases		usd
CY2023Q2	clps	Loans Payable To Bank Two LoansPayableToBankTwo		usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome		pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome		pure
CY2022	clps	Withholding Tax WithholdingTax		pure
CY2023	clps	Effective Income Tax Rate Reconciliation Tax Credits Deferred Tax EffectiveIncomeTaxRateReconciliationTaxCreditsDeferredTax		pure
CY2022	clps	Effective Income Tax Rate Reconciliation Tax Credits Deferred Tax EffectiveIncomeTaxRateReconciliationTaxCreditsDeferredTax		pure
CY2022	clps	Goodwill Provision Tax Rate GoodwillProvisionTaxRate		pure
CY2021	clps	Goodwill Provision Tax Rate GoodwillProvisionTaxRate		pure
CY2022Q2	us-gaap	Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction		usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther		usd
CY2022Q2	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities		usd
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent		usd
CY2023	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2023	clps	Share Options ShareOptions		shares
CY2022	clps	Share Options ShareOptions		shares
CY2023	clps	Earnings Loss Share Rs Us EarningsLossShareRSUs		usd
CY2023	clps	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Intrinsic Value Total ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodIntrinsicValueTotal		usd
CY2023	clps	Amounts Reclassified From Accumulated Other Comprehensive Income AmountsReclassifiedFromAccumulatedOtherComprehensiveIncome		usd
CY2023	us-gaap	Other Comprehensive Income Finalization Of Pension And Non Pension Postretirement Plan Valuation Tax OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax		usd
CY2022	us-gaap	Other Comprehensive Income Finalization Of Pension And Non Pension Postretirement Plan Valuation Tax OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax		usd
CY2021	us-gaap	Other Comprehensive Income Finalization Of Pension And Non Pension Postretirement Plan Valuation Tax OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	00000
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001724542

Files In Submission

Name	View Source	Status
clps-20230630_cal.xml	Edgar Link	unprocessable
clps-20230630_def.xml	Edgar Link	unprocessable
0001013762-23-004641-index-headers.html	Edgar Link	pending
0001013762-23-004641-index.html	Edgar Link	pending
0001013762-23-004641.txt	Edgar Link	pending
0001013762-23-004641-xbrl.zip	Edgar Link	pending
clps-20230630.xsd	Edgar Link	pending
ex10-13_001.jpg	Edgar Link	pending
ex10-13_002.jpg	Edgar Link	pending
ex10-13_003.jpg	Edgar Link	pending
ex10-22_001.jpg	Edgar Link	pending
ex10-22_002.jpg	Edgar Link	pending
ex10-22_003.jpg	Edgar Link	pending
ex10-22_004.jpg	Edgar Link	pending
f20f2023ex10-11_clpsinc.htm	Edgar Link	pending
f20f2023ex10-12_clpsinc.htm	Edgar Link	pending
f20f2023ex10-13_clpsinc.htm	Edgar Link	pending
f20f2023ex10-14_clpsinc.htm	Edgar Link	pending
f20f2023ex10-15_clpsinc.htm	Edgar Link	pending
f20f2023ex10-20_clpsinc.htm	Edgar Link	pending
f20f2023ex10-21_clpsinc.htm	Edgar Link	pending
f20f2023ex10-22_clpsinc.htm	Edgar Link	pending
f20f2023ex10-23_clpsinc.htm	Edgar Link	pending
f20f2023ex12-1_clpsinc.htm	Edgar Link	pending
f20f2023ex12-2_clpsinc.htm	Edgar Link	pending
f20f2023ex13-1_clpsinc.htm	Edgar Link	pending
f20f2023ex21-1_clpsinc.htm	Edgar Link	pending
f20f2023ex23-1_clpsinc.htm	Edgar Link	pending
f20f2023_clpsinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
clps-20230630_lab.xml	Edgar Link	unprocessable
clps-20230630_pre.xml	Edgar Link	unprocessable
f20f2023_clpsinc_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLPS
CLPS Inc Stock $clps

2023 Q3 Form 20-F Financial Statement

#000101376223004641 Filed on October 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLPS CLPS Inc Stock $clps

2023 Q3 Form 20-F Financial Statement

#000101376223004641 Filed on October 18, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLPS
CLPS Inc Stock $clps